A position statement is an official point of view or belief of the ADA. Position statements are issued on scientific or medical issues related to diabetes. They may be authored or unauthored and are published in ADA journals and other scientific/medical publications as appropriate. Position statements must be reviewed and approved by the Professional Practice Committee and, subsequently, by the Executive Committee of the Board of Directors. ADA position statements are typically based on a technical review or other review of published literature. They are reviewed on an annual basis and updated as needed. In addition to those published in this supplement, listed below are recent position statements.
Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation
Michael Pignone, Mark J. Alberts, John A. Colwell, Mary Cushman, Silvio E. Inzucchi, Debabrata Mukherjee, Robert S. Rosenson, Craig D. Williams, Peter W. Wilson, and M. Sue Kirkman
Diabetes Care 33:1395–1402, 2010
Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint Position Statement
Sheri R. Colberg, Ronald J. Sigal, Bo Fernhall, Judith G. Regensteiner, Bryan J. Blissmer, Richard R. Rubin, Lisa Chasan-Taber, Ann L. Albright, and Barry Braun
Diabetes Care 33:e147–e167, 2010
Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes: A Position Statement of the American Diabetes Association and a Clinical Practice Guideline of the Cystic Fibrosis Foundation, Endorsed by the Pediatric Endocrine Society
Antoinette Moran, Carol Brunzell, Richard C. Cohen, Marcia Katz, Bruce C. Marshall, Gary Onady, Karen A. Robinson, Kathryn A. Sabadosa, Arlene Stecenko, and Bonnie Slovis, the CFRD Guidelines Committee
Diabetes Care 33:2697–2708, 2010
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
Jay S. Skyler, Richard Bergenstal, Robert O. Bonow, John Buse, Prakash Deedwania, Edwin A.M. Gale, Barbara V. Howard, M. Sue Kirkman, Mikhail Kosiborod, Peter Reaven, and Robert S. Sherwin
Diabetes Care 32:187–192, 2009
Nutrition Recommendations and Interventions for Diabetes: A Position Statement of the American Diabetes Association
American Diabetes Association
Diabetes Care 31 (Suppl. 1):S61–S78, 2008
Generic Drugs: A Position Statement of the American Diabetes Association
American Diabetes Association
Diabetes Care 30:173, 2007
Pancreas and Islet Transplantation in Type 1 Diabetes: A Position of the American Diabetes Association
American Diabetes Association
Diabetes Care 29:935, 2006
The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes
Richard Kahn, John Buse, Ele Ferrannini, and Michael Stern
Diabetes Care 28:2289, 2005
Diabetic Neuropathies: A Statement by the American Diabetes Association
Andrew J.M. Boulton, Arthur I. Vinik, Joseph C. Arezzo, Vera Bril, Eva L. Feldman, Roy Freeman, Rayaz A. Malik, Raelene E. Maser, Jay M. Sosenko, and Dan Ziegler
Diabetes Care 28:956, 2005
Care of Children and Adolescents With Type 1 Diabetes: A Statement of the American Diabetes Association
Janet Silverstein, Georgeanna Klingensmith, Kenneth Copeland, Leslie Plotnick, Francine Kaufman, Lori Laffel, Larry Deeb, Margaret Grey, Barbara Anderson, Lea Ann Holzmeister, and Nathaniel Clark
Diabetes Care 28:186, 2005
